Gene Therapy Weekly
Susan Hasty, Publisher
Table of Contents . . . April 14th, 1997
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
HIV Gene Therapy - Marriage of HIV-1 and MO-MLV Sets Stage for HIV-1 Gene Therapy
AIDS Therapies - HIV Replication Increased by Drugs That Prevent Cell Suicide
Antisense Technology - Second Generation Chimeras Announced
Cancer Gene Therapy - Canarypox Virus-Mediated Immunotherapy: Success In Vivo
Cancer Gene Therapy - Tumor Transfection with Nitric Oxide Gene Exhibits Bystander Effect
Cancer Gene Therapy (Immunotherapy) - IL-2 Transduced Tumor Cells Effective Against Pancreatic Cancer
Genetics - Annual Meeting Focuses National Attention on Cancer Genetics
Genetics - Artificial Chromosomes Created
Genetics - Gene Involved in Brain, Breast and Prostate Cancers
Genetics - Molecule CD39 Regulates Blood Clotting Initiation
Genetics - Partnership Formed To Link to Genetic Biodiversity
Genetics - Patent Filed for Product Development Protection
Immunology - Compound Procedure Hopes To Regulate Immune System
Industry News (Joint Venture) - Agreement Established To Improve Treatment of Cancer Patients
Industry News (Joint Venture) - Alzheimer's Disease Gene Discovery Collaboration Announced
Industry News (Joint Venture) - Small Molecule Compounds Treat Chronic Anemias
Non-Viral Vectors - Cationic Lipids Successfully Transduce Airway Epithelial Cells
Transplantation - Umbilical Cord Blood Transplants Impact on Human Health
DNA Vaccines (HGV) - "Monoclonal Antibodies to Hepatitis G Virus E2-Protein Generated by DNA-Immunization."
DNA Vaccines (Hepatitis) - "Enhancement of Cellular and Humoral Immune Responses to Hepatitis C Virus (HCV) Core Protein Using DNA Based Vaccines Augmented with Cytokine Expressing Plasmids."
Drug Development (Malaria) - "Organellar DNAS as Targets for Antimalarial Therapy."
Genome Synthesis (HCV) - "Establishment of a Long HCV RT/PCR as a Prerequisite for the Cloning of an Infectious cDNA."
HIV Gene Therapy - "Intracellular Immunization Against HIV-1 Infections: Utility of Single Chain Variable Fragments Against Pre- and Post-Integration Targets."
HIV Gene Therapy - "Potential Molecular Genetic Interventions for AIDS."
Antisense Technology - "Human Serum Reactivity to Porcine Endothelial Cells after Antisense-Mediated Down-Regulation of GpIIIa Expression."
Antisense Technology - "The Inhibitory Effects of Antisense RNA on Hepatitis B Virus Surface Antigen Synthesis."
Cancer Gene Therapy - "Adenovirally Transferred p16(INK4/CDKN2) and p53 Genes Cooperate to Induce Apoptotic Tumor Cell Death."
Cardiology - "Toward Molecular Strategies for Heart Disease: Past, Present, Future."
Cytokines - "Cytokine Signal Networks and a New Era in Biomedical Research."
Gene Expression - "Long-Term Control of Erythropoietin Secretion by Doxycycline in Mice Transplanted with Engineered Primary Myoblasts."
Vascular Tissue - "Antisense Basic Fibroblast Growth Factor Gene Transfer Reduces Neointimal Thickening after Arterial Injury."
Vascular Tissue - "In vivo Gene Transfer into Rat Arterial Walls with Novel Adeno-Associated Virus Vectors."
Vectors - "Recombinant Adeno-Associated Virus for Muscle Directed Gene Therapy."
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
